Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1133 studies found for:    Esophageal Neoplasms
Show Display Options
Rank Status Study
1 Completed Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Cancer of the Esophagus;   Esophagus Cancer;   Esophageal Neoplasm;   Cancer of Esophagus
Interventions: Drug: Irinotecan (drug);   Drug: Taxotere (drug);   Procedure: Radiotherapy (procedure);   Procedure: Esophagectomy (procedure)
2 Recruiting Irreversible Electroporation(IRE) For Unresectable Esophageal Neoplasms
Condition: Esophageal Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
3 Recruiting Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
Conditions: Esophageal Neoplasms;   Esophageal Cancer
Interventions: Radiation: Adjuvant Chemoradiation;   Radiation: Adjuvant Radiation;   Drug: Paclitaxel;   Drug: Cisplatin
4 Recruiting Pembrolizumab With Locally Delivered Radiation Therapy for the Initial Treatment of Metastatic Esophageal Cancers
Conditions: Esophageal Neoplasms;   Esophageal Cancer;   Cancer of the Esophagus
Interventions: Drug: Pembrolizumab;   Radiation: Brachytherapy;   Procedure: Endoscopic biopsy;   Procedure: Ultrasound-guided biopsy;   Procedure: Computed tomography-guided biopsy;   Procedure: Peripheral blood collection
5 Recruiting Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
Conditions: Esophageal Neoplasm;   Esophageal Cancer TNM Staging Primary Tumor (T) T2;   Esophageal Cancer TNM Staging Primary Tumor (T) T3;   Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0;   Esophageal Cancer TNM Staging Distal Metastasis (M) M0
Intervention: Radiation: Prophylactic postoperative radiation therapy
6 Completed Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Capecitabine (Xeloda)
7 Completed Outcomes After Esophageal Cancer Surgery
Conditions: Esophageal Neoplasm;   Esophageal Disease
Intervention: Procedure: Esophagectomy
8 Terminated Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
Conditions: Esophageal Neoplasms;   Carcinoma, Squamous Cell;   Adenocarcinoma;   Esophageal Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: [18-F] Fluorodeoxyglucose (FDG);   Drug: 5-Fluorouracil (5-FU);   Drug: Carboplatin
9 Terminated Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
Conditions: Barrett Esophagus;   Esophageal Neoplasms;   Deglutition Disorders;   GERD;   Neoplasm
Interventions: Device: CSA System (CryoSpray AblationTM System);   Device: CryoSpray Ablation
10 Recruiting Docetaxel and S-1 for Advanced Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: DS (docetaxel+S-1)
11 Completed Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer
Condition: Esophageal Neoplasms
Interventions: Drug: Pronase;   Drug: Control
12 Terminated A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Procedure: Esophagectomy
13 Recruiting Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Ferumoxytol
14 Active, not recruiting Early Detection of Esophageal Cancer
Conditions: Esophageal Neoplasms;   Stomach Neoplasms;   Endoscopy, Gastrointestinal;   Digestive System Endoscopic Surgical Procedures;   Cytology
15 Withdrawn Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Intervention: Genetic: CD40 Gene Transfer
16 Recruiting Apatinib for Metastatic Esophageal Cancer.
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Apatinib
Intervention: Drug: Apatinib
17 Withdrawn Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Condition: Esophageal Neoplasms
Interventions: Genetic: AdcuCD40L;   Genetic: Placebo
18 Recruiting SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Stereotactic Body Radiation Therapy;   Thymalfasin
Interventions: Radiation: Stereotactic Body Radiation Therapy;   Drug: Thymalfasin
19 Completed PET-CT Based Radiotherapy in Esophageal Cancer Patients
Condition: Esophageal Neoplasms
20 Completed
Has Results
Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial
Condition: Esophageal Neoplasm
Interventions: Other: Restrictive group;   Other: Liberal group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years